Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on October 27, 2026

Oct. 27, 2026

Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET

Indeterminate GlobeNewswire

Oct. 27, 2026

Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference

Indeterminate GlobeNewswire

Oct. 27, 2026

Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Oct. 27, 2026

Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases

Indeterminate GlobeNewswire

Oct. 27, 2026

Vertero Completes Patient Enrollment in Phase 1b Clinical Study of VT-5006 – an Investigational Treatment for Parkinson’s Disease

Indeterminate GlobeNewswire

Oct. 27, 2026

Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®

Indeterminate GlobeNewswire

Oct. 27, 2026

Medicus Pharma to Present at BioFuture and Global Biotechnology Summit

Indeterminate GlobeNewswire

Oct. 27, 2026

InflaRx Announces November Investor Events

Indeterminate GlobeNewswire

Oct. 27, 2026

Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131

Indeterminate GlobeNewswire

Oct. 27, 2026

Mammogen and MammoLink Partner to Advance a New Model for Community-Based Breast Cancer Detection

Indeterminate GlobeNewswire

Oct. 27, 2026

Adagene to Participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Oct. 27, 2026

Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET

Indeterminate GlobeNewswire

Oct. 27, 2026

Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Hormone-Free Menopause Supplement for Perimenopause Through Postmenopause Now Available From Calroy Health Sciences

Indeterminate GlobeNewswire

Oct. 27, 2026

Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience

Indeterminate GlobeNewswire

Oct. 27, 2026

Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA

Indeterminate GlobeNewswire

Oct. 27, 2026

Fortrea to Participate in Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Oct. 27, 2026

Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual Congress

Indeterminate GlobeNewswire